ADDvise Group AB (OM:ADDV A) signed a Letter of Intent to acquire Zevex Physical Evaluation for $7.3 million.
The revenue for the last twelve months per June 30, 2021, amounted to approximately $3.3 million, with an EBITDA of approximately $1.1 million. The acquisition is subject to a due diligence and that the parties will agree to enter into a share purchase agreement. The share purchase agreement and completion of the acquisition is scheduled to be completed during Q1, 2022. As of March 3, 2022, the transaction is expected to close by March 3, 2022. The transaction is expected to have a positive impact on ADDvise earnings per share during the financial year 2022. Mangold Fondkommission AB (OM:MANG) acted as the financial advisor to ADDvise Group AB.